Quest Diagnostics, Inc.’s filing revealed that its SVP & General Counsel PREVOZNIK MICHAEL E unloaded Company’s shares for reported $5.04 million on Aug 29 ’24. In the deal valued at $154.97 per share,32,551 shares were sold. As a result of this transaction, PREVOZNIK MICHAEL E now holds 38,478 shares worth roughly $6.04 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, KUPPUSAMY KARTHIK sold 1,990 shares, generating $304,990 in total proceeds. Upon selling the shares at $153.26, the SVP, Clinical Solutions now owns 11,459 shares.
Before that, PREVOZNIK MICHAEL E bought 32,551 shares. Quest Diagnostics, Inc. shares valued at $5,044,516 were divested by the Officer at a price of $154.97 per share.
A number of analysts have revised their coverage, including Citigroup’s analysts, who increased its forecast for the stock in early July from “a Neutral” to “a Buy”. Leerink Partners began covering DGX with “Market perform” recommendation on February 26, 2024. Jefferies revised its rating on February 07, 2024. It rated DGX as “a Buy” which previously was an “a Hold”.
Price Performance Review of DGX
On Tuesday, Quest Diagnostics, Inc. [NYSE:DGX] saw its stock unchanged to $156.97. Over the last five days, the stock has gained 1.99%. Quest Diagnostics, Inc. shares have risen nearly 13.85% since the year began. Nevertheless, the stocks have risen 19.37% over the past one year. While a 52-week high of $157.34 was reached on 09/03/24, a 52-week low of $119.59 was recorded on 02/01/24. SMA at 50 days reached $146.35, while 200 days put it at $136.96.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 155.92, which if violated will result in even more drops to 154.87. On the upside, there is a resistance level at 158.12. A further resistance level may holdings at 159.27. The Relative Strength Index (RSI) on the 14-day chart is 71.11, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.52, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 12.97%. Stochastics %K at 92.86% indicates the stock is a selling.
How much short interest is there in Quest Diagnostics, Inc.?
A steep rise in short interest was recorded in Quest Diagnostics, Inc. stocks on 2024-08-15, growing by 0.51 million shares to a total of 2.79 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 2.28 million shares. There was a rise of 18.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $145 price target.
